To Share or Not to Share Failed Genetic Screening Results with Patients

Read more

If a patient does not screen positive for the targeted genetic variant when being screened for a study, is it advisable or is there any obligation for the study team to disclose the results to the patient? The answer isn’t a simple one. For best practices and considerations for including genetic testing in your clinical development strategy, read our article.


VP, Regulatory Science, Strategy and Innovation
Executive Director, Therapeutic Strategy Lead, Rare Diseases

Want to learn more about Worldwide Clinical Trials?